Cargando…
Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility
The steroid 11beta-hydroxylase inhibitor metyrapone is able to effectively reverse the hypercortisolemia detected in human Cushing’s Syndrome patients. In this current preclinical study, we investigated whether metyrapone monotherapy can also reverse the hypercortisolemia-associated increase in athe...
Autores principales: | van der Sluis, Ronald J., van den Aardweg, Tim, Sijsenaar, Timothy J. P., Van Eck, Miranda, Hoekstra, Menno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526766/ https://www.ncbi.nlm.nih.gov/pubmed/37759687 http://dx.doi.org/10.3390/biom13091287 |
Ejemplares similares
-
Leukocytosis and Enhanced Susceptibility to Endotoxemia but Not Atherosclerosis in Adrenalectomized APOE Knockout Mice
por: Hoekstra, Menno, et al.
Publicado: (2013) -
High-density lipoproteins and non-alcoholic fatty liver disease
por: Hoekstra, Menno, et al.
Publicado: (2023) -
Bone Marrow Ts65Dn Trisomy-Induced Changes in Platelet Functionality and Lymphocytopenia Do Not Impact Atherosclerosis Susceptibility in Mice
por: Korporaal, Suzanne J. A., et al.
Publicado: (2021) -
Hematopoietic upstream stimulating factor 1 deficiency is associated with increased atherosclerosis susceptibility in LDL receptor knockout mice
por: Hoekstra, Menno, et al.
Publicado: (2021) -
PRMT3 inhibitor SGC707 reduces triglyceride levels and induces pruritus in Western-type diet-fed LDL receptor knockout mice
por: de Jong, Laura M., et al.
Publicado: (2022)